Tag: Vaccines
FDA Advisers Say Next Round of COVID-19 Booster Shots Should Target an XBB...
Protection against the original strain of the virus will be dropped from the updated vaccines as it could contribute to lower vaccine efficacy against newer strains.
FDA Advisers Meet to Decide Next COVID-19 Booster Shot
In a briefing paper, scientists say redesigned boosters should target at least one variant of the XBB strains
V114 Pneumococcal Vaccine Has Acceptable Safety Profile for Infants
Generally comparable proportion of infants with injection-site, systemic, vaccine-related, serious adverse events for V114 and PCV13
New Threshold Could Inform Rabies Postexposure Prophylaxis Decisions
Authors say a risk threshold of 0.0004 would be appropriate for postexposure prophylaxis administration
Chikungunya Vaccine Candidate Induces Strong Immune Response
VLA1553 induced seroprotective chikungunya virus neutralizing antibody levels in 98.9 percent of those receiving vaccine
Bladder Cancer Treatment May Lower Risk for Alzheimer and Related Dementias
Greater effect seen for patients aged 70 years and older at time of bacillus Calmette-Guerin vaccination
Decreases in Mpox Vaccination Shortfall Needed in Minorities
To achieve equitable progression in vaccination, decreases in shortfalls needed for Black, AI/AN persons
Third Dose of COVID-19 Vaccine Seems Safe for Young Children
No new safety concerns reported among children aged 6 months to 5 years receiving third dose of mRNA COVID-19 vaccine
FDA Panel Backs RSV Vaccine for Infants, Some Toddlers
Monoclonal antibody shot would protect against RSV in infants born during or entering their first RSV season
FDA Approves Pfizer RSV Vaccine for Older Adults
CDC expected to meet later in the month to adopt vaccine recommendations for older Americans
